1
2
3
4
5
由 Ma, Quanxin, Wang, Kai, Yang, Qinqin, Ping, Shun, Zhao, Weichun, Shou, Qiyang, Zhou, Weimin, Chen, Minli
發表在 Mediators Inflamm (2016)
獲取全文發表在 Mediators Inflamm (2016)
獲取全文
獲取全文
Artigo
6
7
由 Fu, Huiying, Cheng, Hongqiang, Cao, Gang, Zhang, Xingde, Tu, Jue, Sun, Mingjiao, Mou, Xiaozhou, Shou, Qiyang, Ke, Yuehai
發表在 PLoS One (2016)
獲取全文發表在 PLoS One (2016)
獲取全文
獲取全文
Artigo
8
9
由 Shou, Qiyang, Jin, Lu, Lang, Jiali, Shan, Qiyuan, Ni, Zhunan, Cheng, Changpei, Li, Qinglin, Fu, Huiying, Cao, Gang
發表在 Front Pharmacol (2019)
獲取全文發表在 Front Pharmacol (2019)
獲取全文
獲取全文
Artigo
10
由 Shi, Yanan, Zheng, Yingsong, Xu, Jingming, Ding, Bin, Shou, Qiyang, Chen, Guiping, Liu, Ting, Sun, Qiuhua, Xu, Xiaohong
發表在 Evid Based Complement Alternat Med (2021)
獲取全文發表在 Evid Based Complement Alternat Med (2021)
獲取全文
獲取全文
Artigo
11
由 Yan, Ping, Mao, Wen, Jin, Lushuai, Fang, Mingsun, Liu, Xia, Lang, Jiali, Jin, Lu, Cao, Beibei, Shou, Qiyang, Fu, Huiying
發表在 Mediators Inflamm (2020)
獲取全文發表在 Mediators Inflamm (2020)
獲取全文
獲取全文
Artigo
12
由 Zhang, Lizong, Lang, Jiali, Jin, Lu, Jin, Lushuai, Cao, Beibei, Shao, Xia, Fang, Mingsun, Cai, Yueqin, Liu, Xia, Fu, Huiying, Shou, Qiyang
發表在 Evid Based Complement Alternat Med (2020)
獲取全文發表在 Evid Based Complement Alternat Med (2020)
獲取全文
獲取全文
Artigo
13
由 Fu, Huiying, Tang, Biqiang, Lang, Jiali, Du, Yueguang, Cao, Beibei, Jin, Lushuai, Fang, Mingsun, Hu, Zhiming, Cheng, Changpei, Liu, Xia, Shou, Qiyang
發表在 Front Nutr (2020)
獲取全文發表在 Front Nutr (2020)
獲取全文
獲取全文
Artigo
14
由 Yin, Chengyu, Liu, Boyu, Li, Yuanyuan, Li, Xiaojie, Wang, Jie, Chen, Ruixiang, Tai, Yan, Shou, Qiyang, Wang, Ping, Shao, Xiaomei, Liang, Yi, Zhou, Hong, Mi, Wenli, Fang, Jianqiao, Liu, Boyi
發表在 Theranostics (2020)
獲取全文發表在 Theranostics (2020)
獲取全文
獲取全文
Artigo